DETERMINE Trial Treatment Arm 3: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers.
Conditions:  Solid Tumor;  Haematological Malignancy;  Malignancy;  Malignant Neoplasm;  Lymphoproliferative Disorders;  Neoplasms by Histologic Type;  Neoplasms by Site;  Cancer;  Brain Neoplasms;  Melanoma;  Glioma Intervention:  Drug: Entrectinib Sponsors:  Cancer Research UK;  University of Manchester;  University of Birmingham;  Royal Marsden NHS Foundation Trust;  Hoffmann-La Roche Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain Tumor | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Genetics | Glioma | Melanoma | Pediatrics | Research | Skin Cancer